Angelova Magdalena, Ortiz-Meoz Rodrigo F, Walker Suzanne, Knipe David M
Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA
J Virol. 2015 Aug;89(16):8474-83. doi: 10.1128/JVI.01002-15. Epub 2015 Jun 3.
O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) is an essential cellular enzyme that posttranslationally modifies nuclear and cytoplasmic proteins via O-linked addition of a single N-acetylglucosamine (GlcNAc) moiety. Among the many targets of OGT is host cell factor 1 (HCF-1), a transcriptional regulator that is required for transactivation of the immediate-early genes of herpes simplex virus (HSV). HCF-1 is synthesized as a large precursor that is proteolytically cleaved by OGT, which may regulate its biological function. In this study, we tested whether inhibition of the enzymatic activity of OGT with a small molecule inhibitor, OSMI-1, affects initiation of HSV immediate-early gene expression and viral replication. We found that inhibiting OGT's enzymatic activity significantly decreased HSV replication. The major effect of the inhibitor occurred late in the viral replication cycle, when it reduced the levels of late proteins and inhibited capsid formation. However, depleting OGT levels with small interfering RNA (siRNA) reduced the expression of HSV immediate-early genes, in addition to reducing viral yields. In this study, we identified OGT as a novel cellular factor involved in HSV replication. Our results obtained using a small molecule inhibitor and siRNA depletion suggest that OGT's glycosylation and scaffolding functions play distinct roles in the replication cycle of HSV.
Antiviral agents can target viral or host gene products essential for viral replication. O-GlcNAc transferase (OGT) is an important cellular enzyme that catalyzes the posttranslational addition of GlcNAc sugar residues to hundreds of nuclear and cytoplasmic proteins, and this modification regulates their activity and function. Some of the known OGT targets are cellular proteins that are critical for the expression of herpes simplex virus (HSV) genes, suggesting a role for OGT in the replication cycle of HSV. In this study, we found that OGT is required for efficient expression of viral genes and for assembly of new virions. Thus, we identify OGT as a novel host factor involved in the replication of HSV and a potential target for antiviral therapy.
O-连接的N-乙酰葡糖胺(O-GlcNAc)转移酶(OGT)是一种重要的细胞酶,它通过O-连接单个N-乙酰葡糖胺(GlcNAc)部分对核蛋白和细胞质蛋白进行翻译后修饰。OGT的众多靶标之一是宿主细胞因子1(HCF-1),它是一种转录调节因子,是单纯疱疹病毒(HSV)立即早期基因反式激活所必需的。HCF-1最初以一种大的前体形式合成,该前体被OGT进行蛋白水解切割,这可能会调节其生物学功能。在本研究中,我们测试了用小分子抑制剂OSMI-1抑制OGT的酶活性是否会影响HSV立即早期基因表达的起始和病毒复制。我们发现抑制OGT的酶活性会显著降低HSV的复制。该抑制剂的主要作用发生在病毒复制周期的后期,此时它会降低晚期蛋白的水平并抑制衣壳形成。然而,用小分子干扰RNA(siRNA)耗尽OGT水平除了降低病毒产量外,还会降低HSV立即早期基因的表达。在本研究中,我们确定OGT是参与HSV复制的一种新型细胞因子。我们使用小分子抑制剂和siRNA耗尽获得的结果表明,OGT的糖基化和支架功能在HSV的复制周期中发挥着不同的作用。
抗病毒药物可以靶向病毒复制所必需的病毒或宿主基因产物。O-连接的N-乙酰葡糖胺转移酶(OGT)是一种重要的细胞酶,它催化将GlcNAc糖残基翻译后添加到数百种核蛋白和细胞质蛋白上,这种修饰调节它们的活性和功能。一些已知的OGT靶标是对单纯疱疹病毒(HSV)基因表达至关重要的细胞蛋白,这表明OGT在HSV的复制周期中发挥作用。在本研究中,我们发现OGT是病毒基因高效表达和新病毒体组装所必需的。因此,我们确定OGT是参与HSV复制的一种新型宿主因子以及抗病毒治疗的潜在靶标。